Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$429M |
| 2 |
Walt Disney
DIS
|
+$412M |
| 3 |
McDonald's
MCD
|
+$396M |
| 4 |
Goldman Sachs
GS
|
+$382M |
| 5 |
Electronic Arts
EA
|
+$320M |
Top Sells
| 1 |
Amazon
AMZN
|
+$2.12B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$619M |
| 3 |
AT&T
T
|
+$474M |
| 4 |
Synchrony
SYF
|
+$422M |
| 5 |
Honeywell
HON
|
+$366M |
Sector Composition
| 1 | Technology | 15.07% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 10.51% |
| 4 | Industrials | 9.53% |
| 5 | Consumer Discretionary | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
451
DELISTED
Cymabay Therapeutics
CBAY
| $37.3M | 0.02% |
2,805,472
+1,379,650
| +97% | +$18.3M |
|
452
Ovintiv
OVV
$10.6B
| $36.9M | 0.02% |
1,019,771
-3,101,428
| -75% | -$112M |
|
|
DLPH
453
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $36.8M | 0.02% |
1,913,183
-1,263,162
| -40% | -$24.3M |
|
454
Amgen
AMGN
$151B
| $36.8M | 0.02% |
193,620
-118,102
| -38% | -$22.4M |
|
455
LyondellBasell Industries
LYB
$17.6B
| $36.7M | 0.02% |
436,025
+339,077
| +350% | +$28.5M |
|
456
AnaptysBio
ANAB
$621M
| $36.2M | 0.02% |
496,067
+23,502
| +5% | +$1.72M |
|
457
Coca-Cola Europacific Partners
CCEP
$40.9B
| $36M | 0.02% |
695,862
+215,805
| +45% | +$11.2M |
|
458
Ascendis Pharma
ASND
$12.4B
| $36M | 0.02% |
305,876
+209,267
| +217% | +$24.6M |
|
|
BHVN
459
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $36M | 0.02% |
698,775
-239,464
| -26% | -$12.3M |
|
|
TECX
460
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $35.6M | 0.02% |
134,410
+20,855
| +18% | +$5.52M |
|
461
BlackBerry
BB
$2.29B
| $35.5M | 0.02% |
3,521,504
+1,535,368
| +77% | +$15.5M |
|
462
GE Aerospace
GE
$293B
| $35.4M | 0.02% |
711,117
-1,843,117
| -72% | -$91.8M |
|
463
Biogen
BIIB
$20.7B
| $35.3M | 0.02% |
149,416
+13,237
| +10% | +$3.13M |
|
|
NBIS
464
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.3B
| $35.3M | 0.02% |
1,027,551
+787,693
| +328% | +$27M |
|
|
CZR
465
DELISTED
Caesars Entertainment Corporation
CZR
| $35M | 0.02% |
4,026,200
+3,861,107
| +2,339% | +$33.6M |
|
|
NATI
466
DELISTED
National Instruments Corp
NATI
| $34.9M | 0.02% |
787,758
+130,258
| +20% | +$5.78M |
|
467
Chegg
CHGG
$169M
| $34.7M | 0.02% |
910,470
+821,760
| +926% | +$31.3M |
|
|
NEWR
468
DELISTED
New Relic, Inc.
NEWR
| $34.4M | 0.02% |
348,505
+66,865
| +24% | +$6.6M |
|
|
LM
469
DELISTED
Legg Mason, Inc.
LM
| $34.3M | 0.02% |
1,252,625
+967,771
| +340% | +$26.5M |
|
|
ACIA
470
DELISTED
Acacia Communications, Inc. Common Stock
ACIA
| $34.3M | 0.02% |
597,487
+76,761
| +15% | +$4.4M |
|
471
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $34.3M | 0.02% |
2,511,982
+313,172
| +14% | +$4.27M |
|
472
Wendy's
WEN
$1.92B
| $34.2M | 0.02% |
1,911,833
+1,784,304
| +1,399% | +$31.9M |
|
473
Equity Residential
EQR
$25.4B
| $34M | 0.02% |
451,371
+4,031
| +0.9% | +$304K |
|
474
Henry Schein
HSIC
$8.21B
| $34M | 0.02% |
565,144
+391,819
| +226% | +$23.6M |
|
475
MGM Resorts International
MGM
$9.85B
| $34M | 0.02% |
1,323,176
+281,372
| +27% | +$7.22M |
|